Aijun Liu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Multiple Myeloma

Replacement Therapy

Newly Diagnosed

Prognostic Factors

Top Venues

Cancer medicine

Turkish journal of haematology : official journal of Turkish Society of Haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Aijun Liu, Hong Yu, Rui Hou, Zunmin Zhu, Jun-Ling Zhuang, Li Bao, Zhenling Li, Lihong Liu, Luoming Hua, Yanping Ma, Da Gao, Arong Jin, Xiaohui Suo, Wei Yang, Yuansong Bai, Rong Fu, Deqiang Zheng, Wenming Chen
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study. Cancer medicine 13 (9) (2024)
Aijun Liu, Hong Yu, Rui Hou, Zunmin Zhu, Jun-Ling Zhuang, Li Bao, Zhenling Li, Lihong Liu, Luoming Hua, Yanping Ma, Da Gao, Arong Jin, Xiaohui Suo, Wei Yang, Yuansong Bai, Rong Fu, Deqiang Zheng, Wenming Chen
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study. Cancer medicine 13 (9) (2024)
Aijun Liu, Hong Yu, Rui Hou, Zunmin Zhu, Jun-Ling Zhuang, Li Bao, Zhenling Li, Lihong Liu, Luoming Hua, Yanping Ma, Da Gao, Arong Jin, Xiaohui Suo, Wei Yang, Yuansong Bai, Rong Fu, Deqiang Zheng, Wenming Chen
Assessment of prolonged proteasome inhibition through ixazomib-based oral regimen on newly diagnosed and first-relapsed multiple myeloma: A real-world Chinese cohort study. Cancer medicine 13 (9) (2024)
Fang Ye, Tongtong Wang, Aijun Liu, Yanchen Li, Ningning Li, Huan Wang, Wenming Chen
Clinical Significance of TP53 Abnormalities in Newly Diagnosed Multiple Myeloma Turkish journal of haematology : official journal of Turkish Society of Haematology 38 (4) (2021)